Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerrit Frommeyer

Showing results (41-50 of 209) with videos related to

Pageof 21
Sort By:
Pacing and Clinical Electrophysiology : PACE|September 9, 2024
Benefits and limitations of implantable loop recorders in the very elderlyHauke Engelke, Kevin Willy, Florian Reinke, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 1, 2018
Extended ECG monitoring with an implantable loop recorder in patients with cryptogenic stroke: time schedule, reasons for explantation and incidental findings (results from the TRACK-AF trial)Markus Bettin, Dirk Dechering, Simon Kochhäuser, et al.
Cardiovascular Therapeutics|May 8, 2013
Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillationGerrit Frommeyer, Peter Milberg, Timo Uphaus, et al.
Herzschrittmachertherapie & Elektrophysiologie|February 6, 2015
Patients with atrial fibrillation complicated by coronary artery disease. Is a single value of sensitive cardiac troponin I on admission enough?Dirk Bandorski, Harilaos Bogossian, Olaf Braun, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 30, 2018
Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromesChristian Ellermann, Magdalena Sterneberg, Simon Kochhäuser, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 11, 2017
Comparison of vernakalant and ranolazine in atrial fibrillationGerrit Frommeyer, Magdalena Sterneberg, Dirk G Dechering, et al.
Basic & Clinical Pharmacology & Toxicology|November 19, 2016
Colchicine Increases Ventricular Vulnerability in an Experimental Whole-Heart ModelGerrit Frommeyer, Julius Krawczyk, Dirk G Dechering, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|May 25, 2016
Long-time "real-life" performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillationGerrit Frommeyer, Dirk G Dechering, Simon Kochhäuser, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 3, 2015
Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experienceGerrit Frommeyer, Dirk G Dechering, Sven Zumhagen, et al.
Herzschrittmachertherapie & Elektrophysiologie|June 7, 2013
The ECG in cardiovascular-relevant animal models of electrophysiologySven Kaese, Gerrit Frommeyer, Sander Verheule, et al.
Pageof 21

Showing results (41-50 of 209) with videos related to

Sort By:
Pageof 21
Pacing and Clinical Electrophysiology : PACE|September 9, 2024
Benefits and limitations of implantable loop recorders in the very elderlyHauke Engelke, Kevin Willy, Florian Reinke, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|September 1, 2018
Extended ECG monitoring with an implantable loop recorder in patients with cryptogenic stroke: time schedule, reasons for explantation and incidental findings (results from the TRACK-AF trial)Markus Bettin, Dirk Dechering, Simon Kochhäuser, et al.
Cardiovascular Therapeutics|May 8, 2013
Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillationGerrit Frommeyer, Peter Milberg, Timo Uphaus, et al.
Herzschrittmachertherapie & Elektrophysiologie|February 6, 2015
Patients with atrial fibrillation complicated by coronary artery disease. Is a single value of sensitive cardiac troponin I on admission enough?Dirk Bandorski, Harilaos Bogossian, Olaf Braun, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 30, 2018
Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromesChristian Ellermann, Magdalena Sterneberg, Simon Kochhäuser, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 11, 2017
Comparison of vernakalant and ranolazine in atrial fibrillationGerrit Frommeyer, Magdalena Sterneberg, Dirk G Dechering, et al.
Basic & Clinical Pharmacology & Toxicology|November 19, 2016
Colchicine Increases Ventricular Vulnerability in an Experimental Whole-Heart ModelGerrit Frommeyer, Julius Krawczyk, Dirk G Dechering, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|May 25, 2016
Long-time "real-life" performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillationGerrit Frommeyer, Dirk G Dechering, Simon Kochhäuser, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|August 3, 2015
Long-term follow-up of subcutaneous ICD systems in patients with hypertrophic cardiomyopathy: a single-center experienceGerrit Frommeyer, Dirk G Dechering, Sven Zumhagen, et al.
Herzschrittmachertherapie & Elektrophysiologie|June 7, 2013
The ECG in cardiovascular-relevant animal models of electrophysiologySven Kaese, Gerrit Frommeyer, Sander Verheule, et al.
Pageof 21